Introduction
============

The *Disrupted-in-Schizophrenia 1* (*DISC1*) gene was originally discovered at the breakpoint of a balanced translocation t(1;11) (q42;q14.3) in a Scottish family and later identified in a North American family with high rates of schizophrenia.^[@bib1],\ [@bib2],\ [@bib3],\ [@bib4]^ Since then, preclinical models have shown that *DISC1* mutant animals exhibit behavioural, neurostructural and neurochemical features relevant to schizophrenia, ^[@bib5],\ [@bib6]^ although its significance for the human disease has been debated.^[@bib7],\ [@bib8],\ [@bib9]^ DISC1 is described as a scaffold protein with multiple interactors involved in a wide range of cellular processes including neurotransmitter signalling.^[@bib10],\ [@bib11]^ In particular, DISC1 is known to interact with several proteins involved in dopamine signalling including fasciculation and elongation protein zeta 1, phosphodiesterase 4D9 and phosphodiesterase 4B, serine/threonine protein kinase Akt and glycogen synthase kinase-3 (GSK-3)^[@bib12],\ [@bib13],\ [@bib14],\ [@bib15],\ [@bib16]^ as well as synaptic interactors such as kalirin-7 and the Traf2, Nck-interacting kinase,^[@bib17],\ [@bib18]^ and the microtubule/centrosomal proteins pericentriolar material 1 and Bardet--Biedl syndrome protein.^[@bib19],\ [@bib20]^ These multiple interactions have highlighted the potential of DISC1 as a therapeutic target.^[@bib21],\ [@bib22],\ [@bib23]^

The neurotransmitter dopamine is widely thought to have a central role in the aetiology of psychotic disorders.^[@bib24],\ [@bib25],\ [@bib26]^ The dopamine hypothesis of schizophrenia was initially based on the findings that the affinity of antipsychotic medications for dopamine receptors is closely related to their clinical potency,^[@bib27],\ [@bib28],\ [@bib29]^ and that drugs that increase dopamine levels provoke psychotic symptoms in healthy people.^[@bib30],\ [@bib31]^ Molecular imaging studies since then have shown increased presynaptic dopamine synthesis capacity and release in schizophrenia^[@bib32],\ [@bib33],\ [@bib34],\ [@bib35]^ and in subjects with prodromal symptoms of schizophrenia.^[@bib36],\ [@bib37],\ [@bib38],\ [@bib39]^ Alterations in dopamine D1 and D2/3 receptors, tyrosine hydroxylase (TH) levels and baseline synaptic dopamine levels in schizophrenia have also been reported,^[@bib40],\ [@bib41]^ although with some inconsistency.^[@bib42]^

These findings highlight why dopaminergic dysfunction has a pivotal role in schizophrenia. In view of this, we sought to review the evidence from animal models that *DISC1* pathway alterations may impact on dopaminergic function, as it has not been comprehensively synthesised before. The aim of our review was therefore to summarise the impact of DISC1 on TH levels, dopamine transporter (DAT) levels, basal dopamine levels and after amphetamine administration, dopamine D2 receptor-binding potential (BP), dopamine D1 (D1R) and D2 receptor (D2R) levels, and locomotor activity after amphetamine administration for dopamine-related behaviour.^[@bib43]^ We selected publications citing data collection in the midbrain, as this is the location of the majority of dopaminergic neuron cell bodies in the brain, and the frontal cortex, hippocampus and striatum as these are the target sites of the main dopaminergic pathways relevant to psychiatric disorders.^[@bib44],\ [@bib45]^

Materials and methods
=====================

Selection of studies
--------------------

The entire PubMed database was searched to select publications. Studies were screened based on the terms ('Disrupted-in-Schizophrenia-1\' OR '*DISC1*\') AND ('dopamine\' OR 'tyrosine hydroxylase\' OR 'dopamine receptor\' OR 'DAT\' OR 'amphetamine\' OR 'behavioral alterations\' OR 'locomotor activity\' OR 'Positron Emission Tomography\' OR 'PET\' OR 'Single Photon Emission Computed Tomography\' OR 'SPECT\'). Only articles meeting the following criteria were included: (1) original studies; (2) English language; (3) peer-review journals; (4) findings reporting TH levels, DAT levels, basal dopamine levels and/or dopamine levels after amphetamine administration, and/or dopamine receptor-binding potential, dopamine receptor levels and/or locomotion after amphetamine administration in a *DISC1* model compared with a control group; and (5) in the frontal cortex, striatum, nucleus accumbens, midbrain and/or hippocampus, as these regions are major target sites of dopaminergic projections in the brain and are thought to be involved in the pathophysiology of schizophrenia.^[@bib44],\ [@bib45]^ The *DISC1* models were selected based on gene mutation in *DISC1* or alteration in the quantitative expression of DISC1 protein. Method and results sections of the eligible articles were screened to identify the measures of interest listed above.

Data extraction
---------------

The main outcome measures were the differences between the *DISC1* models and controls in (1) TH levels; (2) DAT levels; (3) basal dopamine levels; (4) dopamine levels after amphetamine administration; (5) dopamine receptor-binding potential; (6) D1R and D2R levels; and (7) locomotion after amphetamine administration. In addition, the following data were extracted: (8) authors; (9) year of publication; (10) the *DISC1* model; (11) samples size; and (12) methods. The data were extracted by TD and checked by SVT. Findings related to the nucleus accumbens and olfactory tubercle were merged as both being part of the ventral striatum.^[@bib46]^

Results
=======

Fifty-one studies were excluded from a total of 65 studies screened ([Figure 1](#fig1){ref-type="fig"}). Fourteen studies were included of which two were of TH levels, three of DAT levels, nine of basal dopamine levels, six of induced dopamine release, four of dopamine receptor BP, four studies of D1R levels, four studies of D2R levels and thirteen of locomotion after amphetamine administration. [Table 1](#tbl1){ref-type="table"} summarises all studies including the *DISC1* model used, sample sizes and methods. It should be noted that we were not able to find evidence that dopaminergic function had been investigated in more recently disclosed *DISC1* models, for example.^[@bib47],\ [@bib48]^

*DISC1* models
--------------

Five types of *DISC1* models were identified across the studies as follows: (1) transgenic expression of truncated human *Disc1* protein with dominant-negative (DN) effect; (2) *DISC1* haploinsufficiency/silencing; (3) full-length human *DISC1* overexpression; (4) artificial *Disc1* mutation; and (5) wild-type model ([Table 1](#tbl1){ref-type="table"}). Data on locomotion after amphetamine administration from Su *et al.*^[@bib62]^ were included despite the absence of a direct comparison between mutant and wild-type mice as they showed a functional relationship between Disc1 and the dopamine receptor. Both genotype effects (wild type versus transgenic) and genotype effect in a stress condition (isolated wild type versus isolated transgenics) were included from Niwa *et al.*^[@bib51]^

TH levels
---------

Two studies investigated TH levels in the *hDISC1* and the *Disc1* RNA interference (RNAi)/silencing models compared with controls.^[@bib51],\ [@bib54]^ These studies showed reduced TH levels in frontal cortical regions in isolated *hDISC1* mice compared with isolated controls^[@bib51]^ and in the *Disc1* RNAi/silencing model compared with controls^[@bib54]^ ([Figure 2](#fig2){ref-type="fig"} and Table 3).

One study showed no significant changes in TH levels between *hDISC1* and controls, and between isolated *hDISC1* mice and isolated controls in the nucleus accumbens.^[@bib51]^

DAT levels
----------

Three studies investigated DAT levels in the *DISC1* model compared with controls.^[@bib52],\ [@bib56],\ [@bib58]^ Two studies found increased DAT levels in the striatum of DN homozygous line 37 mice and tg*DISC1* rats compared with controls [Tables 2](#tbl2){ref-type="table"} and [3](#tbl3){ref-type="table"}.^[@bib52],\ [@bib58]^

One study found no significant difference between the *Disc1*Δ2--3 mice compared with controls in the nucleus accumbens.^[@bib56]^

Basal dopamine levels
---------------------

Nine studies investigated basal dopamine levels in *DISC1* models compared with controls.^[@bib49],\ [@bib50],\ [@bib51],\ [@bib52],\ [@bib54],\ [@bib56],\ [@bib58],\ [@bib59],\ [@bib61]^ *In vivo* microdialysis and *post-mortem* high-performance liquid chromatography with electrochemical detection (HPLC-ED) were used, measuring extracellular and total dopamine levels, respectively.

Eight studies investigated basal dopamine levels in the frontal cortex/mPFC, six using HPLC-ED^[@bib49],\ [@bib50],\ [@bib55],\ [@bib58],\ [@bib59],\ [@bib61]^ and two using both *post-mortem* HPLC-ED and microdialysis.^[@bib51],\ [@bib54]^ One of the two studies using microdialysis showed decreased basal dopamine levels in the *Disc1* RNAi/silencing model compared to controls,^[@bib54]^ whereas the other study found no significant changes between the *hDISC1* mice and controls and the isolated *hDISC1* mice and isolated controls.^[@bib51]^ For HPLC-ED, decreased basal dopamine levels were found at postnatal day 56 in the *Disc1* RNAi/silencing model,^[@bib54]^ and in males from the prenatal *hDISC1* expression group (until embryonic day 17), the postnatal expression group (from embryonic day 17 on) groups and the pre- and postnatal *hDISC1* expression (entire life) compared with controls.^[@bib49]^ No significant differences were reported in the other studies.^[@bib50],\ [@bib51],\ [@bib55],\ [@bib58],\ [@bib59],\ [@bib61]^

Six studies investigated basal dopamine levels in the striatum using HPLC-ED^[@bib49],\ [@bib50],\ [@bib51],\ [@bib55],\ [@bib58],\ [@bib61]^ and one using both HPLC-ED and microdialysis.^[@bib59]^ One study found decreased total dopamine levels in the full-length *DISC1*-overexpressing rat model compared with controls in the dorsal striatum.^[@bib58]^

Six studies investigated basal dopamine levels in the nucleus accumbens, one using *in vivo* microdialysis,^[@bib52]^ four using HPLC-ED^[@bib49],\ [@bib58],\ [@bib59],\ [@bib61]^ and one using both techniques.^[@bib54]^ Two studies using *in vivo* microdialysis showed decreased basal dopamine levels in the *Disc1* RNAi/silencing model compared with controls^[@bib54]^ and the *hDISC1* heterozygous line 10 and 37 mice compared with controls.^[@bib52]^ One study using HPLC-ED showed significant decreased basal dopamine levels in L100P ENU-generated missense mutation mice,^[@bib61]^ whereas the others found no significant differences.^[@bib49],\ [@bib54],\ [@bib58],\ [@bib59]^

One study investigated basal dopamine levels in the midbrain and found no significant difference between the *Disc1*Δ2--3 haploinsufficiency model and controls.^[@bib55]^

Seven studies investigated basal dopamine levels in the hippocampus using HPLC-ED.^[@bib49],\ [@bib50],\ [@bib54],\ [@bib55],\ [@bib58],\ [@bib59],\ [@bib61]^ One study found decreased dopamine levels in females in the postnatal *hDISC1* expression group compared with prenatal expression only and controls.^[@bib49]^ The other studies found no significant differences.^[@bib50],\ [@bib54],\ [@bib55],\ [@bib58],\ [@bib59],\ [@bib61]^

Induced dopamine release
------------------------

All the studies induced dopamine release by administrating amphetamine-related drugs. Two studies investigated induced dopamine release in the frontal cortex and found no significant differences, one using microdialysis^[@bib51]^ and one using HPLC-ED.^[@bib50]^

One study investigated induced dopamine release in the striatum using *in vivo* microdialysis^[@bib59]^ and one study using HPLC-ED,^[@bib50]^ both reporting no significant differences.

Four studies investigated induced dopamine release in the nucleus accumbens using microdialysis.^[@bib51],\ [@bib52],\ [@bib54],\ [@bib56]^ The four studies found significantly increased dopamine release. This was in the *DISC1* knockdown compared with controls,^[@bib54]^ in isolated *hDISC1* compared with isolated controls,^[@bib51]^ in heterozygous line 10 and 37 compared with controls ^[@bib52]^ and female but not male *Disc1*Δ2--3 mice compared with controls.^[@bib56]^

One study investigated induced dopamine release in the hippocampus using HPLC-ED and found no significant difference between the *hDISC1* and controls.^[@bib50]^

Dopamine D1 receptor
--------------------

Two studies investigated D1R levels in the frontal cortex and found no significant differences between the *hDISC1* and controls, and the *Disc1*Δ2--3 haploinsufficiency model and controls.^[@bib51],\ [@bib56]^

Three studies investigated D1R levels in the striatum.^[@bib52],\ [@bib56],\ [@bib58]^ One study found increased levels in the *hDISC1* model compared with controls,^[@bib52]^ whereas the others found no significant differences.^[@bib56],\ [@bib58]^

Two studies investigated D1R levels in the nucleus accumbens.^[@bib51],\ [@bib56]^ One study found significant increased D1R levels in female and no significant changes in male and mixed *Disc1*Δ2--3 groups,^[@bib56]^ whereas the other showed no significant differences.^[@bib51]^

Dopamine D2 receptor
--------------------

Three studies investigated D2R levels in the frontal cortex.^[@bib51],\ [@bib54],\ [@bib56]^ One study found significant increased D2R levels in the *hDISC1* mice compared with controls and isolated *hDISC1* mice compared with isolated controls^[@bib51]^ and the two other studies found no significant differences between the *Disc1* RNAi/silencing/haploinsufficiency models and controls.^[@bib54],\ [@bib56]^

Two studies investigated D2R levels in the striatum.^[@bib52],\ [@bib56]^ The *hDISC1* mice showed significant increased D2R levels,^[@bib52]^ whereas the other showed no significant differences between the *Disc1*Δ2--3 models and controls.^[@bib56]^

Four studies investigated dopamine receptor-binding potential in the striatum.^[@bib50],\ [@bib52],\ [@bib58],\ [@bib59]^ The dopamine D2 receptor is known to exist in two interconverting states, a low-affinity (μ[m]{.smallcaps}) and a high-affinity (n[m]{.smallcaps}) state.^[@bib63]^ Lipina *et al.*^[@bib59]^ and Trossbach *et al.*^[@bib58]^ found a significant increase in dopamine D2 high-affinity receptor levels using \[^3^H\]domperidone binding challenged with dopamine, but Trossbach *et al.* found no difference in \[^3^H\]raclopride binding by autoradiography. As raclopride does not distinguish low from high affinity or D2 from D3 receptors, taken together, these studies are consistent with a shift to the high-affinity state without a change in total D2/3 receptor levels. Jaaro-Peled *et al.*^[@bib52]^ found significantly increased binding potential of D2/3 receptor availability in the striatum using \[^11^C\]raclopride PET and significantly increased levels of D2/3R in the medial part of the right rostral striatum using \[^3^H\]spiperone autoradiography but no significant differences in D2/3 levels in the total right rostral striatum and the lateral part of the right striatum in the *hDISC1* compared with controls. Pogorelov *et al.*^[@bib50]^ found no significant difference in the rostral part of the striatum using \[^11^C\]raclopride autoradiography in the *hDISC1* mice compared with controls.

Two studies investigated D2R levels in the nucleus accumbens.^[@bib51],\ [@bib56]^ One study found significantly increased D2R levels in female but not male and mixed *Disc1*Δ2--3 groups,^[@bib56]^ whereas the other showed no significant differences.^[@bib51]^

One study investigated D2/3R-binding potential in the nucleus accumbens using \[^11^C\]raclopride autoradiography PET and found no significant differences in the nucleus accumbens but significantly decreased levels in the right olfactory tubercle of female *hDISC1* mice compared with controls.^[@bib50]^ They used the same approach to investigate D2/3R-binding potential using \[^11^C\]raclopride autoradiography in the midbrain (substantia nigra/VTA) and found no significant difference between the *hDISC1* and controls.^[@bib50]^

One study investigated D2R levels in the hippocampus and found no significant difference between the *Disc1*Δ2--3 haploinsufficiency and controls.^[@bib56]^

Locomotion after amphetamine administration
-------------------------------------------

Thirteen studies investigated locomotion after amphetamine administration.^[@bib49],\ [@bib50],\ [@bib51],\ [@bib52],\ [@bib53],\ [@bib54],\ [@bib55],\ [@bib56],\ [@bib57],\ [@bib58],\ [@bib59],\ [@bib60],\ [@bib62]^ Ten studies found increased locomotion after amphetamine administration in the *DISC1* models compared with control animals, in the pre- and postnatal *hDISC1* expression groups,^[@bib49]^ *hDISC1* mice,^[@bib52]^ the *Disc1* RNAi/silencing model,^[@bib54]^ female but not male *Disc1*Δ2--3 mice,^[@bib55]^ male but not female *Disc1*Δ2--3 mice,^[@bib56]^ full-length *hDISC1*-overexpressing rats,^[@bib57],\ [@bib58]^ *Disc1*-L100P mice,^[@bib59]^ isolated *hDISC1* mice compared with isolated controls^[@bib51]^ and wild-type *Disc1* mice with no *DISC1*--D2R disruption.^[@bib62]^ Two studies found decreased locomotion after amphetamine administration, in female but not male *hDISC1* mice after escalating dose of methamphetamine treatment compared with controls in Pogorelov *et al.*^[@bib50]^ and wild-type mice with *Disc1*--D2R disruption in Su *et al.*^[@bib62]^ No significant changes were found in the *hDISC1* mice and *Disc1*-L100P/L100P mice compared with controls in three studies.^[@bib51],\ [@bib53],\ [@bib60]^

Discussion
==========

The main findings show that compared with controls, the *DISC1* models exhibit reasonably consistent (1) increased locomotion after amphetamine administration (2) increased dopamine levels after amphetamine administration in the nucleus accumbens but (3) inconsistent alterations in basal dopamine levels and dopamine receptor levels and binding potentials. These findings extend other studies showing increased methamphetamine-induced dopamine release in the nucleus accumbens and locomotor hyperactivity in mice lacking DISC1-interacting proteins, such as fasciculation and elongation protein zeta 1^[@bib64]^ and PDE4,^[@bib65]^ to indicate that the *DISC1* pathway affects specific aspects of dopaminergic function.

Limitations
-----------

The findings presented in this systematic review must be considered in the light of the following limitations. First, the number of studies was modest for some aspects of dopaminergic function, such as transporter levels, and some regions. This limits the conclusions that can be drawn about these aspects, and highlights the needs for further studies. Second, the studies used a heterogeneous set of *DISC1* models ([Table 1](#tbl1){ref-type="table"}), which could contribute to variability in results. Third, the evidence comes from a relatively small number of research groups. Thus, replication would be useful to determine generalisability. And fourth, alterations in other neurotransmitter system such as noradrenaline might also contribute to the locomotor hyperactivity phenotype observed. However, several reports indicate that locomotor hyperactivity after amphetamine is specifically mediated through dopamine and not noradrenergic transmission in the nucleus accumbens.^[@bib66],\ [@bib67],\ [@bib68]^

Potential mechanisms underlying locomotor hyperactivity
-------------------------------------------------------

The majority of the *DISC1* models used showed locomotor hyperactivity following amphetamine challenge. This shows a relatively conserved phenotype of the *DISC1* models that might be explained by (1) the presynaptic effects of *DISC1* on dopamine release in the nucleus accumbens or (2) a direct impact of the *DISC1* models on postsynaptic dopaminergic signal transduction, such as the protein serine/threonine protein kinase (Akt)--glycogen synthase kinase-3 (GSK-3) pathway. In support of the first hypothesis, the nucleus accumbens is thought to have an important role in regulating locomotor activity.^[@bib69],\ [@bib70]^ Local administration of dopamine and amphetamine has been shown to induce hyperactivity similar to systemic administration,^[@bib66],\ [@bib70],\ [@bib71],\ [@bib72]^ and our review has identified reasonably consistent evidence that *DISC1* models are associated with greater dopamine release to amphetamine. With regards to the second hypothesis, Akt and GSK-3 are two proteins regulated by DISC1 with respectively indirect and direct interactions.^[@bib15],\ [@bib16],\ [@bib73]^ The Akt--GSK-3 pathway modulates dopamine neurotransmission and amphetamine-mediated locomotor activity.^[@bib74],\ [@bib75],\ [@bib76]^ Amphetamine/methamphetamine-induced dopamine release decreases Akt activation (phosphorylation state^[@bib77]^), which activates GSK-3 by dephosphorylating the Serine 9 site^[@bib78]^ to modulate dopamine-dependent behaviours.^[@bib74]^ Although Disc1 wild-type protein decreases Akt and GSK-3 activation,^[@bib15],\ [@bib73],\ [@bib79]^ the impact of mutant DISC1 on Akt and GSK-3 is less clear. Evidence shows increased and decreased Akt activation in *DISC1* knockdown,^[@bib15],\ [@bib62],\ [@bib80]^ no effects on Akt and GSK-3 levels in *hDISC1* mice^[@bib50]^ and consistently increased GSK-3 activation in *DISC1* knockdown and *Disc1* point mutation Q31L.^[@bib62],\ [@bib81],\ [@bib82]^ Interestingly, mice overexpressing GSK-3 develop locomotor hyperactivity,^[@bib83]^ *GSK-3* knockdown mice express reduced locomotor activity^[@bib84]^ and administration of GSK-3 inhibitor decreases amphetamine-induced hyperactivity.^[@bib85]^

Potential mechanisms underlying increased dopamine release to amphetamine
-------------------------------------------------------------------------

The studies reporting increased dopamine levels following amphetamine administration in the nucleus accumbens used a *Disc1*Δ2--3 haploinsufficiency,^[@bib56]^ a DN *hDISC1* model in combination with adolescent isolation stress,^[@bib51]^ a transient knockdown in prefrontal cortex ^[@bib54]^ and a DN *hDISC1* model targeting specifically pyramidal neurons of the cortex and hippocampus.^[@bib52]^ This raises the questions of (1) the time course of changes in dopamine and whether there are developmental periods that are particularly vulnerable to DISC1 alterations, (2) the brain regions minimally required to lead to increased dopamine release to amphetamine, and in particular, the role of the cortical regions in regulating the nucleus accumbens dopamine levels.

With regards to the first point, recent studies suggest that DISC1 alterations interact with stress to impact on dopaminergic neurons during adolescence.^[@bib51],\ [@bib86]^ These findings are in line with evidence showing that adolescence is a critical time life for the development of psychotic disorders including schizophrenia.^[@bib87]^ With regards to the second point, a possible mechanism underlying increased dopamine levels in the nucleus accumbens could be a reduction in cortical parvalbumin-positive interneurons. Supporting this, studies have shown a decreased number of parvalbumin-positive interneurons in the cortex of DN *DISC1* models.^[@bib49],\ [@bib88],\ [@bib89],\ [@bib90]^ Parvalbumin-positive interneurons are GABAergic inhibitory neurons thought to regulate the dopaminergic activity in the nucleus accumbens and to have a role in schizophrenia through the modulation of cortical glutamate excitatory pyramidal neurons.^[@bib91],\ [@bib92],\ [@bib93]^ Finally, the specific localisation of the findings in the nucleus accumbens might be related to an increased sensitivity of this region to stimulants, as it has been shown to release more dopamine following amphetamine administration compared with other striatal subdivisions.^[@bib94]^

Inconsistent basal dopamine levels and dopamine receptor-binding potential and levels
-------------------------------------------------------------------------------------

We summarise here a series of inconsistent findings on basal dopamine levels and dopamine receptor-binding potentials and levels in the frontal cortex, striatum, nucleus accumbens and hippocampus. These findings might be due the heterogeneity of the *DISC1* models used ([Table 1](#tbl1){ref-type="table"}). Among these, only the short interfering RNA knockdown or knockout models should have loss of function phenotypes whereas all others could have either loss of function, or gain of function, or combined phenotypes at the same time. However, no more consistency is observed when looking only at the loss of function models. It should also be noted that the tg*DISC1* rat was conceived as a model for protein pathology related to DISC1 rather than a model for mutant *DISC1*.^[@bib58],\ [@bib95]^ Another possible explanation could be that these are adaptive changes not always seen following the core dopamine release alteration.

Implications
------------

The effects of DISC1 on dopamine release and the behavioural effects of amphetamine are in line with evidence showing increased amphetamine-induced dopamine release in schizophrenia, and that this positively correlates with amphetamine-induced positive psychotic symptoms.^[@bib34],\ [@bib35],\ [@bib96],\ [@bib97]^ The absence of clear receptor changes is also consistent with the lack of changes in dopamine D2/3 receptors alterations seen in a meta-analysis of *in vivo* findings in schizophrenia.^[@bib98]^ However, the inconsistent findings in striatal basal dopamine levels do not agree with the *in vivo* evidence showing increased basal dopamine levels in schizophrenia.^[@bib33],\ [@bib99]^ Taken together, these findings indicate that *DISC1* alterations may increase the risk of schizophrenia by dysregulating the presynaptic regulation of dopamine but they do not result in the full dopaminergic phenotype, suggesting other factors must interact with DISC1. Stress is one likely candidate factor^[@bib100]^ that has been shown increase dopamine release in psychosis.^[@bib38]^

It should be noted that *DISC1* is also associated with affective disorders including major depression.^[@bib101],\ [@bib102]^ The implications of the findings for this association remains unclear, as human PET studies have shown decreased dopamine synthesis capacity in patients with major depression particularly in individuals with reduced affect or psychomotor slowing symptoms^[@bib103],\ [@bib104],\ [@bib105]^ and some endophenotypes such as anhedonia are thought to be underlined by dopamine function.^[@bib106],\ [@bib107]^

Our conclusions drawn from the preclinical research reviewed here may have interesting implications for clinical research and hence translational value at pointing to the necessity of identifying a biomarker to identify illness subtypes related to DISC1 dysfunction, to guide treatment choice and as a lead for the development of novel therapies. Determining whether DISC1 function is aberrant in a given individual could be a useful to subtype patients. Given that aberrant DISC1 function modulates aspects of dopaminergic function, this may help identify patients who may be responsive to drugs that act on the dopaminergic system, in line with emerging evidence on dopaminergic and non-dopaminergic subtypes of schizophrenia.^[@bib108]^ What directions could the search for identifying biomarkers for aberrant DISC1 function take? Screening for DISC1 polymorphisms may be one way to assess this as some polymorphisms have been associated with different neuronal functions and with treatment-resistant schizophrenia.^[@bib109],\ [@bib110],\ [@bib111]^ As it has been demonstrated that single-nucleotide polymorphisms of DISC1-interacting genes are overrepresented in schizophrenia,^[@bib112]^ the use of a DISC1-interactome polygenic risk score might also be a complementary approach to stratify the risk associated with a specific signalling pathway or response to treatment. However, it should be recognised that genetic diagnostics alone may not provide sufficient information because DISC1 levels also depend on other factors, for example, BACE1-dependent cleavage of neuregulin 1.^[@bib113]^ Large cohort studies of patients are needed to determine whether *DISC1* polymorphisms and/or DISC1 protein levels in peripheral cells do identify subsets of patients with distinct illness characteristics or treatment response.^[@bib114]^ This may require the combinatorial analysis of blood-based, imaging and/or neurophysiological factors, to both identify those patients with both aberrant DISC1 and neuronal function. Another key implication is that understanding how *DISC1* alterations lead to dopamine dysregulation could identify new treatment approaches to address the dopamine dysfunction seen in schizophrenia and people at risk of schizophrenia in a broader sense. Pharmacological targeting of aberrant DISC1 function may be able to correct dopamine dysfunction without directly interfering with dopamine receptors themselves, providing an alternative to existing antipsychotic drugs, which are all D2/3 receptor blockers. In that sense, clinical development of diagnostics and pharmacotherapy of DISC1-related disorders may go hand in hand^[@bib95]^ to support the development of precision medicine in psychiatry.

Future directions
-----------------

We identify four key lines of direction for future studies based on the findings: first, as results to date come from a relative small number of studies, it would be useful to investigate dopamine function in *DISC1* models recently developed.^[@bib47],\ [@bib48]^ Second, the mechanism by which *DISC1* leads to increased dopamine release to amphetamine needs further investigation, in particular to determine whether this could be mediated by disinhibition of parvalbumin-positive interneurons or the Akt--GSK-3 pathway. Interestingly, a *DISC1* model has been recently developed with selective knockdown of interneuronal DISC1 in parvalbumin neurons,^[@bib47]^ which might provide insightful knowledge on the mechanisms linking *DISC1* and dopamine regulations. In that context, it is also remarkable that *DISC1* as a single factor is able to both regulate dopamine neuroanatomy as well as parvalbumin-positive interneuron placement in cortical layers.^[@bib115]^ Third, elevated dopamine synthesis capacity is the other aspect of presynaptic dopamine dysregulation widely linked to schizophrenia and people at risk of schizophrenia.^[@bib36],\ [@bib37],\ [@bib116]^ Thus, future work should test if *DISC1* alterations affect this aspect of presynaptic dopamine function in humans. Fourth, it would be useful to examine further the impact of environmental stress on dopamine release and dopamine levels in *DISC1* models as proposed by some authors.^[@bib51],\ [@bib117]^

Conclusions
===========

Compared with controls, the majority of the *DISC1* models but not all exhibits (1) increased locomotion after amphetamine administration and (2) increased dopamine levels after amphetamine administration in the nucleus accumbens but (3) inconsistent basal dopamine levels and dopamine receptor levels and binding potentials. This suggests that presynaptic dopamine dysregulation is a potential mechanism for the increased rates of psychotic disorders seen in the original *DISC1* families and *DISC1* variant carriers, and identifies a number of potential therapeutic targets for treating or even preventing schizophrenia based on the *DISC1* pathway.
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###### *DISC1* models with available dopamine-related data

  *DISC1 model category*                                      *Authors*^ref.^    *Functional impact on DISC1*                                                                                         *Method*                                                                                                                                                                                                        *Rodent strain*                                                                                                                                  *Promoter*                             *Affected brain regions*                                                    *Time of functional effect of mutation*                                        
  ---------------------------------------------------------- ----------------- -------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------- -------------------------------------------------- -------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Transgenic expression of C-terminally truncated *hDISC1*          1\.            Ayhan *et al.*^[@bib49]^                       Expression of C-terminally truncated human *DISC1* (1--598) protein leading to decreased levels of WT *Disc1*; reported dominant-negative effect                                                                                      Tet-Off system: expression under condition without doxycycline; transgene induction at different time points                                                                     Mouse: mixed background (B6; SJL; CBA)   CaMKII promoter (Tet-Off; doxycycline dependent)   Expression mainly in pyramidal neurons of the forebrain and hippocampus, also in basal ganglia, amygdala, thalamus   Four groups: (1) Post and prenatal *hDISC1* expression (entire life; pre+post). (2) Prenatal expression only (until embryonic day 17; pre). (3) Postnatal expression only (from embryonic day 17; post). (4) No *hDISC1* expression (no)
                                                                    2\.          Pogorelov *et al.*^[@bib50]^                     Expression of C-terminally truncated human *DISC1* (1--598) protein leading to decreased levels of WT *Disc1*; reported dominant-negative effect                                                                                                             Tet-Off system: expression under condition without doxycycline                                                                                                       Mouse: C57BL/6 J              CaMKII promoter (Tet-Off; doxycycline dependent)   Expression mainly in pyramidal neurons of the forebrain and hippocampus, also in basal ganglia, amygdala, thalamus                                                                                                                     ---
                                                                    3\.            Niwa *et al.*^[@bib51]^                        Expression of C-terminally truncated human *DISC1* (1--598) protein leading to decreased levels of WT *Disc1*; reported dominant-negative effect                                                                                                                                          ---                                                                                                                                      Mouse: C57BL/6                                 PrP promoter                                        Expressed widely in the brain (including cortex, striatum, NAc, hippocampus)                                                                                                                                        ---
                                                                    4\.         Jaaro-Peled *et al.*^[@bib52]^   C-terminally truncated human *DISC1* (1--598) protein forming a dimer with WT protein leading to abnormal function and subcellular distribution; reported dominant-negative effect   Dominant-negative *DISC1* model expressed under the control of the CaMKII promoter. Two lines of DN-*DISC1* transgenic male mice: homozygous and heterozygous line 37 (higher transgene expression compared to line 10) and heterozygous line 10              Mouse: C57BL/6 N              CaMKII promoter (Tet-Off; doxycycline dependent)   Expression mainly in pyramidal neurons of the forebrain and hippocampus, also in basal ganglia, amygdala, thalamus                                                                                                                     ---
                                                                    5\.             Ma *et al.*^[@bib53]^                         Expression of C-terminally truncated human *DISC1* (1--598) protein leading to decreased levels of WT *Disc1*; reported dominant-negative effect                                                                                                                                          ---                                                                                                                                     Mouse: C57BL/6J                                GFAP promoter                                                                         Astrocytes                                                                                                                                                                         ---
  *Disc1* haploinsufficiency/silencing                              6\.            Niwa *et al.*^[@bib54]^                                                                Transient knockdown of *Disc1* (spatially restricted, bilateral)                                                                                                                                                           *In utero* injection of *Disc1* short-hairpin RNA                                                                                                                 Mouse: ICR                                   H1 promoter                                                          Pyramidal neurons of the prefrontal cortex                                                                                                                                   Pre- and perinatal stages (E14 up to minimum P7)
                                                                    7\.           Kuroda *et al.*^[@bib55]^                               Haploinsufficiency: *Disc1*Δ2--3/Δ2--3 mice lacking exons 2 and 3 of *Disc1* gene with deficiency of full-length *Disc1* protein                                                                                                                                  Backcross generation of mutant mice                                                                                                                  Mouse: C57BL/6JJmsSlc                               Endogenous                                                                             ---                                                                                                                                                                             ---
                                                                    8\.            Nakai *et al.*^[@bib56]^                               Haploinsufficiency: *Disc1*Δ2--3/Δ2--3 mice lacking exons 2 and 3 of *Disc1* gene with deficiency of full-length *Disc1* protein                                                                                                                                  Backcross generation of mutant mice                                                                                                                  Mouse: C57BL/6JJmsSlc                               Endogenous                                                                             ---                                                                                                                                                                             ---
  Full-length *hDISC1* overexpression                               9\.           Vomund *et al.*^[@bib57]^                                                         Full-length human *DISC1* overexpression (spatially restricted, lateralized)                                                                                                                                                  *In utero* electroporation of plasmids into rat embryos                                                                                                         Rat: Sprague-Dawley                             CMV IE promoter                                                                  Left prefrontal cortex                                                                                                                                                         Prenatal to adult stages
                                                                   10\.          Trossbach *et al.*^[@bib58]^                                                         Full-length human *DISC1* overexpression leading to aggregation of DISC1                                                                                                                                               Injection of cosmid carrying the transgene into pronuclei of rats                                                                                                    Rat: Sprague-Dawley                       Syrian Hamster PrP promoter                                             Expressed in all regions and cell types in the brain                                                                                                                                                    ---
  Artificial *Disc1* mutation                                      11\.           Lipina *et al.*^[@bib59]^                         Missense mutation in exon 2: T334C transition leading to a leucine to proline substitution at amino acid 100 in the *Disc1* protein (L100P)                                                                                                                               ENU-induced artificial mutation                                                                                                                       Mouse: C57BL/6J                                  Endogenous                                                                             ---                                                                                                                                                                             ---
                                                                   12\.            Arime *et al.*^[@bib60]^                         Missense mutation in exon 2: T334C transition leading to a leucine to proline substitution at amino acid 100 in the *Disc1* protein (L100P)                                                                                                                               ENU-induced artificial mutation                                                                                                                       Mouse: C57BL/6J                                  Endogenous                                                                             ---                                                                                                                                                                             ---
                                                                   13\.           Lipina *et al.*^[@bib61]^                             Missense mutation in exon 2: A127T transition leading to a glutamine to leucine substitution at amino acid 31 in the protein (Q31L)                                                                                                                                   ENU-induced artificial mutation                                                                                                                       Mouse: C57BL/6J                                  Endogenous                                                                             ---                                                                                                                                                                             ---
  Wild-type *Disc1*                                                 14              Su *et al.*^[@bib62]^                                                                                          Wild-type mice                                                                                                                                                                                                           ---                                                                                                                                     Mouse: C57BL/6J                                  Endogenous                                                                             ---                                                                                                                                                                             ---

Abbreviations: ENU, *N*-nitroso-*N*-ethylurea; *hDISC1*, human *DISC1*; GFAP promoter, glial fibrillary acidic protein promoter; GSK-3, glycogen synthase kinase-3; PDE4B, phosphodiesterase 4B---enzyme inactivating intra-cellular adenosine 3′,5′-monophosphate (cAMP); PrP, prion protein; tg*DISC1*, transgenic *DISC1*; WT, wild type.

###### Methods

  *DISC1 model category*                                      *Authors*^ref.^  *Animals*                        n                                                                *Gender*               *Measures*        *Brain regions*                                                                                                                                                                                                                    *Technique*                 
  ---------------------------------------------------------- ----------------- -------------------------------- --------------------------------------------------- ----------------------------------- ----------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------ ----------------------------------------------------------------------------------------------------------
  Transgenic expression of C-terminally truncated *hDISC1*          1\.        Ayhan *et al.*^[@bib49]^         Pre+postnatal *hDISC1* (1--598) mice                               6--8                 Male              Locomotion in the open-field test (60 min) after amphetamine administration (1 mg kg^−1^, i.p.)                                                                                                                                        ---                     Behavioural analysis
                                                                                                                Prenatal *hDISC1* (1--598) mice                                                                                                                                                                                                                                                                                                                                           
                                                                                                                Postnatal *hDISC1* (1--598) mice                                                                                                                                                                                                                                                                                                                                          
                                                                                                                Controls                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                All groups                                                       FC: 5--6               Male              *Post-mortem* total dopamine levels                                                                                                                                                                                              FC, striatum, HC              HPLC-ED
                                                                                                                                                                                 HC: 4--6               Female                                                                                                                                                                                                                                                                            
                                                                                                                                                                              Striatum: 4--5            Male and female                                                                                                                                                                                                                                                                   
                                                                    2\.        Pogorelov *et al.*^[@bib50]^     *hDISC1* (1--598) mice                                             8--12                Male and female   Locomotion in the open-field test (30 min) after 2 weeks treatment with non-toxic escalating dose of methamphetamine (0.5--3.0 mg kg^−1^, i.p.) vs saline administration                                                               ---                     Behavioural analysis
                                                                                                                Controls                                                           8--12                Male and female                                                                                                                                                                                                                                                                   
                                                                                                                *hDISC1* (1--598) mice                                             3--5                 Female            Locomotion in the open-field test (10 min) 5 weeks after treatment with non-toxic escalating dose of methamphetamine (0.5--3.0 mg kg^−1^, i.p.) and a 1 mg kg^−1^ challenge dose of methamphetamine (1 mg kg^−1^)                      ---                     Behavioural analysis
                                                                                                                Controls                                                           3--5                 Female                                                                                                                                                                                                                                                                            
                                                                                                                *hDISC1* (1--598) mice                                               4                  Not stated        *Post-mortem* total dopamine levels after 2 weeks treatment with non-toxic escalating dose of methamphetamine (0.5--3.0 mg kg^−1^, i.p.)                                                                                         FC, striatum, HC              HPLC-ED
                                                                                                                Controls                                                             4                  Not stated                                                                                                                                                                                                                                                                        
                                                                                                                *hDISC1* (1--598) mice                                               4                  Female            Dopamine D2/3 R-binding potential in treatment naïve mice                                                                                                                                                            OT, NAc, striatum, substantia nigra, VTA  \[^11^C\]raclopride quantitative autoradiography
                                                                                                                Controls                                                             4                  Female                                                                                                                                                                                                                                                                            
                                                                    3\.        Niwa *et al.*^[@bib51]^          *hDISC1* (1--598) mice                               18--23 (9--10 male, 9--13 female)  Male and female   Locomotion after methamphetamine administration (1 mg kg^−1^, i.p.)                                                                                                                                                                    ---                     Behavioural analysis
                                                                                                                Isolated *hDISC1* (1--598) mice                                                         Male and female                                                                                                                                                                                                                                                                   
                                                                                                                WT                                                                                      Male and female                                                                                                                                                                                                                                                                   
                                                                                                                Isolated WT                                                                             Male and female                                                                                                                                                                                                                                                                   
                                                                                                                *hDISC1* (1--598) mice                                               6                  Male              Extracellular dopamine levels after amphetamine administration (1 mg kg^−1^, i.p.)                                                                                                                                                   FC, NAc                   *In vivo* microdialysis
                                                                                                                Isolated *hDISC1* (1--598) mice                                      6                  Male                                                                                                                                                                                                                                                                              
                                                                                                                WT                                                                   6                  Male                                                                                                                                                                                                                                                                              
                                                                                                                Isolated WT                                                          6                  Male                                                                                                                                                                                                                                                                              
                                                                                                                *hDISC1* (1--598) mice                                               6                  Male              Extracellular dopamine levels                                                                                                                                                                                                           FC                     *In vivo* microdialysis
                                                                                                                Isolated *hDISC1* (1--598) mice                                      6                  Male                                                                                                                                                                                                                                                                              
                                                                                                                WT                                                                   6                  Male                                                                                                                                                                                                                                                                              
                                                                                                                Isolated WT                                                          6                  Male                                                                                                                                                                                                                                                                              
                                                                                                                *hDISC1* (1--598) mice                                               7                  Male              *Post-mortem* total dopamine levels                                                                                                                                                                                                  FC, CPu                   HPLC-ED
                                                                                                                Isolated *hDISC1* (1--598) mice                                      7                  Male                                                                                                                                                                                                                                                                              
                                                                                                                WT                                                                   7                  Male                                                                                                                                                                                                                                                                              
                                                                                                                Isolated WT                                                          7                  Male                                                                                                                                                                                                                                                                              
                                                                                                                *hDISC1* (1--598) mice                                               6                  Male              D2R levels                                                                                                                                                                                                                           FC, NAc                   Western blot
                                                                                                                Isolated *hDISC1* (1--598) mice                                      6                  Male                                                                                                                                                                                                                                                                              
                                                                                                                WT                                                                   6                  Male                                                                                                                                                                                                                                                                              
                                                                                                                Isolated WT                                                          6                  Male                                                                                                                                                                                                                                                                              
                                                                                                                *hDISC1* (1--598) mice                                               6                  Male              D1R levels                                                                                                                                                                                                                           FC, NAc                   Western blot
                                                                                                                Isolated *hDISC1* (1--598) mice                                      6                  Male                                                                                                                                                                                                                                                                              
                                                                                                                WT                                                                   6                  Male                                                                                                                                                                                                                                                                              
                                                                                                                Isolated WT                                                          6                  Male                                                                                                                                                                                                                                                                              
                                                                                                                *hDISC1* (1--598) mice                                               6                  Male              TH levels                                                                                                                                                                                                                            FC, NAc                   Western blot
                                                                                                                Isolated *hDISC1* (1--598) mice                                      6                  Male                                                                                                                                                                                                                                                                              
                                                                                                                WT                                                                   6                  Male                                                                                                                                                                                                                                                                              
                                                                                                                Isolated WT                                                          6                  Male                                                                                                                                                                                                                                                                              
                                                                    4\.        Jaaro-Peled *et al.*^[@bib52]^   Heterozygous *hDISC1* (1--598) (line 37)                             5                  Male              Locomotion in the open field (90 min) after methamphetamine administration (1 mg kg^−1^, i.p.)                                                                                                                                         ---                     Behavioural analysis
                                                                                                                Heterozygous *hDISC1* (1--598) (line 10)                             5                  Male                                                                                                                                                                                                                                                                              
                                                                                                                Controls                                                             6                  Male                                                                                                                                                                                                                                                                              
                                                                                                                Heterozygous *hDISC1* (1--598) (1--598) (line 37)                    5                  Male              Extracellular dopamine levels after methamphetamine administration (1 mg kg^−1^, i.p.)                                                                                                                                           Ventral striatum              *In vivo* microdialysis
                                                                                                                Heterozygous *hDISC1* (1--598) (line 10)                             5                  Male                                                                                                                                                                                                                                                                              
                                                                                                                Controls                                                             6                  Male                                                                                                                                                                                                                                                                              
                                                                                                                Heterozygous *hDISC1* (1--598) (line 37)                             8                  Male              DAT levels                                                                                                                                                                                                                           Striatum                  Western blot
                                                                                                                Heterozygous *hDISC1* (1--598) (line 10)                            15                  Male                                                                                                                                                                                                                                                                              
                                                                                                                Controls                                                            15                  Male                                                                                                                                                                                                                                                                              
                                                                                                                Heterozygous *hDISC1* (1--598) (line 37)                             3                  Male              D2/3 R-binding potential striatum/cerebellum ratios                                                                                                                                                                                  Striatum                  \[^11^C\]raclopride PET
                                                                                                                Controls                                                             3                  Male                                                                                                                                                                                                                                                                              
                                                                                                                Homozygous *hDISC1* (1--598) (line 37)                               6                  Male              D2R-binding potential                                                                                                                                                                                                                Striatum                  \[^3^H\]spiperone autoradiography
                                                                                                                Controls                                                             5                  Male                                                                                                                                                                                                                                                                              
                                                                                                                Homozygous *hDISC1* (1--598) (line 37)                               7                  Male              D2R levels                                                                                                                                                                                                                           Striatum                  Real-time PCR
                                                                                                                Controls                                                             9                  Male                                                                                                                                                                                                                                                                              
                                                                    5\.        Ma *et al.*^[@bib53]^            GFAP-*hDISC1* mice                                                  13                  Male              Locomotion in the open-field test (30 min) after amphetamine administration (2.5 mg kg^−1^, i.p.)                                                                                                                                      ---                     Behavioural analysis
                                                                                                                                                                                    10                  Female                                                                                                                                                                                                                                                                            
                                                                                                                Controls                                                            15                  Male                                                                                                                                                                                                                                                                              
                                                                                                                                                                                    10                  Female                                                                                                                                                                                                                                                                            
  *Disc1* haploinsufficiency / silencing                            6\.        Niwa *et al.*^[@bib54]^          *Disc1* RNAi/silencing mice                                        6--10                Not reported      Locomotion in the open-field test (30 min) after methamphetamine administration (1 mg kg^−1^, s.c.)                                                                                                                                    ---                     Behavioural analysis
                                                                                                                Controls                                                           6--10                Not reported                                                                                                                                                                                                                                                                      
                                                                                                                *Disc1* RNAi/silencing mice                                          6                  Not reported      Extracellular dopamine levels                                                                                                                                                                                                          mPFC                    *In vivo* microdialysis
                                                                                                                Controls                                                             6                  Not reported                                                                                                                                                                                                                                                                      
                                                                                                                *Disc1* RNAi/silencing mice                                 7 (FC), 4 (NAc, HC)         Not reported      *post-mortem* total dopamine levels                                                                                                                                                                                                FC, NAc, HC                 HPLC-ED
                                                                                                                Controls                                                    7 (FC), 4 (NAc, HC)         Not reported                                                                                                                                                                                                                                                                      
                                                                                                                *Disc1* RNAi/silencing mice                                          8                  Not reported      Extracellular dopamine levels and levels after methamphetamine administration (1 mg kg^−1^, s.c.) at P56                                                                                                                               NAc                     *In vivo* microdialysis
                                                                                                                Controls                                                             8                  Not reported                                                                                                                                                                                                                                                                      
                                                                                                                *Disc1* RNAi/silencing mice                                  8 (mRNA), 5 (WB)           Not reported      D2R levels                                                                                                                                                                                                                             mPFC                    Western blot and mRNA expression
                                                                                                                Controls                                                     8 (mRNA), 5 (WB)           Not reported                                                                                                                                                                                                                                                                      
                                                                                                                *Disc1* RNAi/silencing mice                                  8 (mRNA), 5 (WB)           Not reported      D1R levels                                                                                                                                                                                                                              FC                     Western blot and mRNA expression
                                                                                                                Controls                                                     8 (mRNA), 5 (WB)           Not reported                                                                                                                                                                                                                                                                      
                                                                                                                *Disc1* RNAi/silencing mice                                   6 (IHC), 5 (WB)           Not reported      TH levels                                                                                                                                                                                                                              mPFC                    Western blot, immunohistochemistry
                                                                                                                Controls                                                      6 (IHC), 5 (WB)           Not reported                                                                                                                                                                                                                                                                      
                                                                    7\.        Kuroda *et al.*^[@bib55]^        *Disc1*+/+ mice                                                      8                  Male              Locomotion in the open-field test (180 min) after methamphetamine administration (2 mg kg^−1^, i.p.)                                                                                                                                   ---                     Behavioural analysis
                                                                                                                                                                                    10                  Female                                                                                                                                                                                                                                                                            
                                                                                                                *Disc1*Δ2--3/Δ2--3 mice                                             10                  Male                                                                                                                                                                                                                                                                              
                                                                                                                                                                                    10                  Female                                                                                                                                                                                                                                                                            
                                                                                                                *Disc1*+/+                                                           7                  Not stated        *post-mortem* total dopamine levels                                                                                                                                                                                        mPFC, striatum, HC, midbrain        HPLC-ED
                                                                                                                *Disc1*Δ2--3/Δ2--3                                                   9                  Not stated                                                                                                                                                                                                                                                                        
                                                                    8\.        Nakai *et al.*^[@bib56]^         *Disc1*+/+                                                           8                  Male              Extracellular dopamine levels after amphetamine administration (2 mg kg^−1^, i.p.)                                                                                                                                                     NAc                     *In vivo* microdialysis
                                                                                                                                                                                     6                  Female                                                                                                                                                                                                                                                                            
                                                                                                                *Disc1*Δ2--3/Δ2--3                                                  10                  Male                                                                                                                                                                                                                                                                              
                                                                                                                                                                                     6                  Female                                                                                                                                                                                                                                                                            
                                                                                                                *Disc1*+/+                                                           6                  Male              DAT levels                                                                                                                                                                                                                             NAc                     Western blot
                                                                                                                                                                                     6                  Female                                                                                                                                                                                                                                                                            
                                                                                                                *Disc1*Δ2--3/Δ2--3                                                   6                  Male                                                                                                                                                                                                                                                                              
                                                                                                                                                                                     6                  Female                                                                                                                                                                                                                                                                            
                                                                                                                *Disc1*+/+                                                           5                  Male              D2R levels                                                                                                                                                                                                                   mPFC, striatum, NAc, HC           Real-time PCR
                                                                                                                                                                                     5                  Female                                                                                                                                                                                                                                                                            
                                                                                                                *Disc1*Δ2--3/Δ2--3                                                   5                  Male                                                                                                                                                                                                                                                                              
                                                                                                                                                                                     5                  Female                                                                                                                                                                                                                                                                            
  full-length *hDISC1* overexpression                               9\.        Vomund *et al.*^[@bib57]^        Full-length *hDISC1*-overexpressing rats                            11                  Not stated        Locomotion in the open-field test (15 min) after amphetamine administration (0.5 mg kg^−1^, i.p.)                                                                                                                                      ---                     Behavioural analysis
                                                                                                                Control rats                                                        10                  Not stated                                                                                                                                                                                                                                                                        
                                                                   10\.        Trossbach *et al.*^[@bib58]^     Homozygous tg*DISC1* rats                                           12                  Male              Locomotion in the open-field test (15 min) after [d]{.smallcaps}-amphetamine administration (0.5 mg kg^−1^, i.p.)                                                                                                                      ---                     Behavioural analysis
                                                                                                                Control rats                                                        12                  Male                                                                                                                                                                                                                                                                              
                                                                                                                Homozygous tg*DISC1* rats                                            6                  Male              Synaptic DAT levels                                                                                                                                                                                                                  Striatum                  Western blot
                                                                                                                Control rats                                                         6                  Male                                                                                                                                                                                                                                                                              
                                                                                                                Homozygous tg*DISC1* rats                                            6                  Male              High-affinity D2^High^ receptor levels                                                                                                                                                                                               Striatum                  \[^3^H\]domperidone 2 n[m]{.smallcaps}, non-specific binding defined with 10μ[m]{.smallcaps} S-sulpiride
                                                                                                                Control rats                                                         6                  Male                                                                                                                                                                                                                                                                              
                                                                                                                Homozygous tg*DISC1* rats                                           10                  Male              D2/3 R-binding potential                                                                                                                                                                                                             Striatum                  *In vitro* autoradiography \[^3^H\]raclopride
                                                                                                                Control rats                                                        10                  Male                                                                                                                                                                                                                                                                              
                                                                                                                Homozygous tg*DISC1* rats                                           12                  Male              *post-mortem* total dopamine levels                                                                                                                                                                                          mPFC, NAc, striatum, HC           HPLC-ED
                                                                                                                Control rats                                                        12                  Male                                                                                                                                                                                                                                                                              
                                                                                                                Homozygous tg*DISC1* rats                                           10                  Male              D1R density                                                                                                                                                                                                                          Striatum                  \[^3^H\]SCH23390 autoradiography
                                                                                                                Control rats                                                        10                  Male                                                                                                                                                                                                                                                                              
  Artificial *Disc1* mutation                                      11\.        Lipina *et al.*^[@bib59]^        *Disc1*-L100P mice                                                 7--9                 Male              Locomotion in the open-field test (30 min) after [d]{.smallcaps}-amphetamine administration (0.5, 1.0 and 1.5 mg kg^−1^, s.c.)                                                                                                         ---                     Behavioural analysis
                                                                                                                Controls                                                           7--10                Male                                                                                                                                                                                                                                                                              
                                                                                                                *Disc1*-L100P mice                                                   6                  Male              Extracellular dopamine levels after amphetamine administration (0.5 mg kg^−1^, s.c.)                                                                                                                                                 Striatum                  *In vivo* microdialysis
                                                                                                                Controls                                                             6                  Male                                                                                                                                                                                                                                                                              
                                                                                                                *Disc1*-L100P mice                                                   7                  Male              *post-mortem* total dopamine levels                                                                                                                                                                                           FC, striatum, NAc, HC            HPLC-ED
                                                                                                                Controls                                                             8                  Male                                                                                                                                                                                                                                                                              
                                                                                                                *Disc1*-L100P mice                                                   7                  Male              High-affinity D2^High^ receptor levels                                                                                                                                                                                               Striatum                  \[^3^H\]domperidone 2 n[m]{.smallcaps}, non-specific binding defined with 10μ[m]{.smallcaps} S-sulpiride
                                                                                                                Controls                                                             8                  Male                                                                                                                                                                                                                                                                              
                                                                   12\.        Arime *et al.*^[@bib60]^         *Disc1*-L100P/L100P mice                                          11--12                Male              Locomotion in the open-field test (60 min) after methamphetamine administration (0.2, 0.5 or 1 mg kg^−1^, s.c.)                                                                                                                        ---                     Behavioural analysis
                                                                                                                *Disc1*-L100P/+ mice                                              11--13                Male                                                                                                                                                                                                                                                                              
                                                                                                                +/+ mice (control)                                                 8--9                 Male                                                                                                                                                                                                                                                                              
                                                                   13\.        Lipina *et al.*^[@bib61]^        *Disc1*-Q31L                                                         7                  Male              *post-mortem* total dopamine levels                                                                                                                                                                                           FC, striatum, NAc, HC            HPLC-ED
                                                                                                                Controls                                                             7                  Male                                                                                                                                                                                                                                                                              
  Wild-type *Disc1*                                                14\.        Su *et al.*^[@bib62]^            WT+saline treated                                                  8--12                Male              Locomotion in the open-field test (30 min) after [d]{.smallcaps}-amphetamine administration (1 mg kg^−1^, i.p.).                                                                                                                       ---                     Behavioural analysis
                                                                                                                WT+TAT-D2pep                                                       8--12                Male                                                                                                                                                                                                                                                                              
                                                                                                                WT+TAT-D2pep-sc                                                    8--12                Male                                                                                                                                                                                                                                                                              

Abbreviations: Amph, amphetamine; CPu, caudate/putamen; DAT, dopamine transporter; *DISC1*D2--3/D2--3, mice lacking exons 2 and 3 of the *DISC1* gene; D2R, dopamine D2 receptor; D2/3 R, dopamine D2 and D3 receptor; FC, frontal cortex; HC, hippocampus; HPLC-ED, high-performance liquid chromatography electro-detection; i.p., intraperitoneally; KD, knockdown; Meth, methamphetamine; mPFC, medial prefrontal cortex; NAc, nucleus accumbens; OT, olfactory tubercles; RNAi, RNA interference; s.c., subcutaneously; TAT-D2pep, peptide disrupting the *Disc1*--D2R interaction; TAT-D2pep-sc, corresponding scrambled peptide; TH, tyrosine hydroxylase.
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